Loud And Clear: EMA Gets Message On Advancing Reg Science
Challenge Is Making Headroom To Discuss Implementing The Changes
Executive Summary
The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.
You may also be interested in...
EU Panel Sets Ambitious Big Data Workplan
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.
Single Annual EMA Fee Proposal Holds Most Promise For Pharma
Europe’s research-based industry association picks its preferred way forward for simplifying the European Medicines Agency’s fee system.
UK Tackles GCP Concerns Over Electronic Health Records
As NHS Trusts switch from paper-based to electronic health records, concerns have arisen about the compatibility of EHR systems with the clinical trials legislation in some cases.